Objectively based on the Phase II trials we know:
BIT225-treated cleared HIV virus faster than those on ART alone:
- 72% of BIT225/ART group vs 33% of placebo/ART reached limited of detection by day 28
- Rate of decline of virus levels in critical second phase of decay was statistically higher in BIT225/ART group vs placebo/ART
This alone is worth something to someone. (the question is how much – C14 will tell us soon )
We can then overlay this with the potential applications of the technology to other viruses (of which this work has already commenced)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.654M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $210 | 104.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 64 | 38848316 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 18281126 | 25 |
View Market Depth
| Last trade - 12.28pm 27/06/2025 (20 minute delay) ? |
| BIT (ASX) Chart |